Gavin P. Reynolds

21.8k total citations · 2 hit papers
329 papers, 16.7k citations indexed

About

Gavin P. Reynolds is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Gavin P. Reynolds has authored 329 papers receiving a total of 16.7k indexed citations (citations by other indexed papers that have themselves been cited), including 167 papers in Cellular and Molecular Neuroscience, 102 papers in Molecular Biology and 98 papers in Psychiatry and Mental health. Recurrent topics in Gavin P. Reynolds's work include Neuroscience and Neuropharmacology Research (97 papers), Neurotransmitter Receptor Influence on Behavior (83 papers) and Schizophrenia research and treatment (77 papers). Gavin P. Reynolds is often cited by papers focused on Neuroscience and Neuropharmacology Research (97 papers), Neurotransmitter Receptor Influence on Behavior (83 papers) and Schizophrenia research and treatment (77 papers). Gavin P. Reynolds collaborates with scholars based in United Kingdom, China and United States. Gavin P. Reynolds's co-authors include Peter Riederer, Clare L. Beasley, Zhi Jun Zhang, K. A. Jellinger, E. Sofić, Shona L. Kirk, Joanna C. Neill, Xiaobin Zhang, Sally J. Pearson and Martin N. Rossor and has published in prestigious journals such as Nature, Science and The Lancet.

In The Last Decade

Gavin P. Reynolds

319 papers receiving 16.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains

1989 1.1k citations Gavin P. Reynolds et al. profile →
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain

1988 591 citations Gavin P. Reynolds et al. Journal of Neural Transmission profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gavin P. Reynolds United Kingdom	72	7.7k	5.0k	4.2k	2.7k	2.6k	329	16.7k
Alan A. Wilson Canada	75	8.3k 1.1×	4.4k 0.9×	3.8k 0.9×	1.6k 0.6×	2.1k 0.8×	328	19.0k
John Seibyl United States	66	6.3k 0.8×	3.1k 0.6×	4.6k 1.1×	2.7k 1.0×	4.4k 1.7×	312	17.0k
Sami S. Zoghbi United States	61	6.1k 0.8×	3.6k 0.7×	2.3k 0.5×	1.4k 0.5×	2.5k 1.0×	271	14.2k
Masaomi Iyo Japan	60	6.8k 0.9×	4.3k 0.8×	2.9k 0.7×	1.2k 0.4×	969 0.4×	405	15.3k
Mark J. Millan France	70	10.4k 1.3×	7.0k 1.4×	2.3k 0.5×	5.0k 1.9×	1.3k 0.5×	284	19.3k
Akira Sawa United States	73	5.2k 0.7×	10.8k 2.1×	2.3k 0.6×	2.2k 0.8×	1.4k 0.5×	325	20.4k
Lars Oreland Sweden	61	5.1k 0.7×	3.1k 0.6×	1.9k 0.4×	1.8k 0.7×	1.6k 0.6×	346	13.5k
Jean Lud Cadet United States	71	9.4k 1.2×	5.4k 1.1×	1.3k 0.3×	1.9k 0.7×	1.6k 0.6×	359	17.5k
Vahram Haroutunian United States	79	6.3k 0.8×	9.7k 1.9×	3.0k 0.7×	7.0k 2.6×	1.4k 0.5×	334	21.9k
Giorgio Racagni Italy	67	8.0k 1.0×	4.7k 0.9×	1.8k 0.4×	2.0k 0.7×	866 0.3×	363	16.4k

Countries citing papers authored by Gavin P. Reynolds

Since Specialization

Citations

This map shows the geographic impact of Gavin P. Reynolds's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gavin P. Reynolds with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gavin P. Reynolds more than expected).

Fields of papers citing papers by Gavin P. Reynolds

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gavin P. Reynolds. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gavin P. Reynolds. The network helps show where Gavin P. Reynolds may publish in the future.

Co-authorship network of co-authors of Gavin P. Reynolds

This figure shows the co-authorship network connecting the top 25 collaborators of Gavin P. Reynolds. A scholar is included among the top collaborators of Gavin P. Reynolds based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gavin P. Reynolds. Gavin P. Reynolds is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Reynolds, Gavin P.. (2024). Understanding the Therapeutic Action of Antipsychotics: Not yet Beyond Striatal Dopamine? A Comment on Direktor et al. (2024). The International Journal of Neuropsychopharmacology. 27(7). 1 indexed citations

Chen, Chen, et al.. (2023). Proteomic association with age-dependent sex differences in Wisconsin Card Sorting Test performance in healthy Thai subjects. Scientific Reports. 13(1). 20238–20238.

Loureiro, Camila Marcelino, Helene Fachim, Fabiana Corsi‐Zuelli, et al.. (2021). The relationship of childhood trauma and DNA methylation of NMDA receptor genes in first-episode schizophrenia. Epigenomics. 13(12). 927–937. 6 indexed citations

Thanoi, Samur, et al.. (2021). Changes of BDNF exon IV DNA methylation are associated with methamphetamine dependence. Epigenomics. 13(12). 953–965. 14 indexed citations

Fachim, Helene, Camila Marcelino Loureiro, Kirk Siddals, et al.. (2020). Circulating microRNA changes in patients with impaired glucose regulation. Adipocyte. 9(1). 443–453. 12 indexed citations

Loureiro, Camila Marcelino, Helene Fachim, Fabiana Corsi‐Zuelli, et al.. (2020). Epigenetic-Mediated N -Methyl-D-Aspartate Receptor Changes in the Brain of Isolated Reared Rats. Epigenomics. 12(22). 1983–1997. 8 indexed citations

Cooper, Stephen, Gavin P. Reynolds, Elizabeth England, et al.. (2016). BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment. Journal of Psychopharmacology. 30(8). 717–748. 186 indexed citations

Zhang, Zhi Jun, et al.. (2012). The Effect of Chronic Antipsychotic Drug on Hypothalamic Expression of Neural Nitric Oxide Synthase and Dopamine D2 Receptor in the Male Rat. PLoS ONE. 7(4). e33247–e33247. 7 indexed citations

Xu, Zhi, Zhijun Zhang, Mengjia Pu, et al.. (2011). Influence and interaction of genetic polymorphisms in the serotonin system and life stress on antidepressant drug response. Journal of Psychopharmacology. 26(3). 349–359. 59 indexed citations

10.

Reynolds, Lindsay M. & Gavin P. Reynolds. (2010). Differential regional N-acetylaspartate deficits in postmortem brain in schizophrenia, bipolar disorder and major depressive disorder. Journal of Psychiatric Research. 45(1). 54–59. 42 indexed citations

11.

Reynolds, Gavin P., Lucy A. Templeman, & Zhi Jun Zhang. (2005). The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 29(6). 1021–1028. 105 indexed citations

12.

Templeman, Lucy A., Gavin P. Reynolds, Belén Arranz, & Luis San. (2005). Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis. Pharmacogenetics and Genomics. 15(4). 195–200. 215 indexed citations

13.

Harte, Michael, Susan B. Powell, Lindsay M. Reynolds, et al.. (2004). Reduced n-acetylaspartate in the temporal cortex of rats reared in isolation. Biological Psychiatry. 56(4). 296–299. 27 indexed citations

14.

Davis, Ben, et al.. (1997). Deficits of [3H]d-aspartate binding to glutamate uptake sites in striatal and accumbens tissue in patients with schizophrenia. Neuroscience Letters. 232(1). 13–16. 28 indexed citations

15.

Wong, Erik H.F., et al.. (1995). Characterization of [3H]GR 113808 binding to 5-HT4 receptors in brain tissues from patients with neurodegenerative disorders. Behavioural Brain Research. 73(1-2). 249–252. 60 indexed citations

16.

Reynolds, Gavin P., et al.. (1992). Dopamine receptor abnormalities in the striatum and pallidum in tardive dyskinesia: a post mortem study. Journal of Neural Transmission. 87(3). 225–230. 12 indexed citations

17.

Reynolds, Gavin P. & Carole Czudek. (1988). Status of the dopaminergic system in post-mortem brain in schizophrenia.. PubMed. 24(3). 345–7. 18 indexed citations

18.

Rossor, Martin N., L L Iversen, Gavin P. Reynolds, C.Q. Mountjoy, & Martin Roth. (1984). Neurochemical characteristics of early and late onset types of Alzheimer's disease.. BMJ. 288(6422). 961–964. 322 indexed citations

19.

Reynolds, Gavin P., Martin N. Rossor, & L Iversen. (1983). PRELIMINARY STUDIES OF HUMAN CORTICAL 5-HT2 RECEPTORS AND THEIR INVOLVEMENT IN SCHIZOPHRENIA AND NEUROLEPTIC DRUG-ACTION. UCL Discovery (University College London). 5 indexed citations

20.

Gozani, T., et al.. (1978). Coal elemental analysis by prompt-neutron activation analysis. Transactions of the American Nuclear Society. 28. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact